Back to results
US 12,509,417 B2Granted
Enantioselective process
AssigneeSyngenta Crop Protection AG
InventorsTomas Smejkal, Nicolai Cramer, Josep Mas-Rosello
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel processes for the enantioselective iridium-catalysed hydrogenation of oximes and oxime ethers to provide compounds of formula (II) and salts thereof formula (I) and (II).
Claims16
A process for hydrogenation of oximes of formula (I) in the presence of an iridium catalyst and an acid to produce a hydroxylamine of formula (II):
- wherein the position labelled with the asterisk is an asymmetric center and one stereoisomer of hydroxylamine of formula (II) is produced in excess;
- R1 and R2 are each independently C1-C8alkyl, C1-C8hydroxyalkyl, C1-C8cyanoalkyl, C1-C6alkoxyC1-C8alkyl, C1-C8haloalkyl, C2-C6alkenyl, C3-C8cycloalkyl, phenyl, phenylC1-C3alkyl, phenylsulfonylC1-C3alkyl, C1-C6alkoxycarbonyl, a bridged carbocyclyl, heterocyclyl or heteroaryl, wherein the cycloalkyl, phenyl, heterocyclyl and heteroaryl moieties are each optionally substituted with 1 to 5 groups selected from hydroxyl, halogen, C1-C6alkyl, C3-C8cycloalkyl, C1-C6haloalkyl, C1-C6alkoxy, phenyl, heteroaryl, C1-C6alkoxycarbonyl, acylamino, amido, cyano, nitro, azido, and C2-C6alkenyl;
- or a single group selected from pinacolborane, phenylsulfonyl, phenylC1-C3alkyl, or phenylC1-C3alkoxy;
- R3 is hydrogen, C1-C8alkyl, C1-C8hydroxyalkyl, C1-C8cyanoalkyl, C1-C6alkoxyC1-C8alkyl, C1-C8haloalkyl, C2-C6alkenyl, C3-C8cycloalkyl, phenylC1-C3alkyl, heterocyclylC1-C3alkyl or heterobicyclylC1-C3alkyl, wherein the cycloalkyl and heterocyclyl moieties are each optionally substituted with 1 to 5 groups selected from hydroxyl, halogen, C1-C6alkyl, C3-C8cycloalkyl, C1-C6haloalkyl, C1-C6alkoxy, phenyl, heteroaryl, C1-C6alkoxycarbonyl, acylamino, amido, cyano, azido, nitro and C2-C6alkenyl;
- and wherein R1 and R2 cannot be the same;
- or
- R1 and R2 together with the carbon atom to which they are attached may form a 4- to 9-membered saturated or partially saturated asymmetric cycloalkyl or asymmetric heterocyclyl ring, wherein the heterocyclic moiety is a non-aromatic monocyclic ring which comprises 1, 2 or 3 heteroatoms, wherein the heteroatoms are individually selected from N, O and S;
- or
- R1 and R3 together with the carbon and oxygen atoms to which they are respectively attached, may form a 5- to 8-membered non-aromatic heterocyclyl ring, or an 8- to 10-membered partially saturated heterobicyclyl;
- wherein the iridium catalysts of formula (IIIa) and (IIIb) are:
- Wherein
- represents an optionally substituted cyclopentadienyl ligand;
- represents a bidentate chelating ligand comprising at least one carbon atom which coordinates to iridium and at least one nitrogen atom which coordinates to iridium;
- X represents an anionic group;
- Y represents a neutral ligand;
- and
- Z represents an anionic group.
14 more elements
Dependencies are inferred from the claim text.